Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018 (2018), Article ID 4120458, 13 pages
https://doi.org/10.1155/2018/4120458
Review Article

Recent Advances in Studies on the Therapeutic Potential of Dietary Carotenoids in Neurodegenerative Diseases

1Department of Biological Sciences, Konkuk University, Seoul 05029, Republic of Korea
2Disease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea
3Department of Bioscience, University of Science and Technology, Daejeon 34113, Republic of Korea
4Department of Brain and Cognitive Sciences, DGIST, Daegu 42988, Republic of Korea

Correspondence should be addressed to Sunhong Kim; rk.er.bbirk@gnohnus and Sung Bae Lee; rk.ca.tsigd@eelbs

Received 22 November 2017; Revised 22 February 2018; Accepted 13 March 2018; Published 16 April 2018

Academic Editor: Julio B. Daleprane

Copyright © 2018 Kyoung Sang Cho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. I. Krinsky and E. J. Johnson, “Carotenoid actions and their relation to health and disease,” Molecular Aspects of Medicine, vol. 26, no. 6, pp. 459–516, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Demmig-Adams, A. M. Gilmore, and W. Adams, “Carotenoids 3: in vivo function of carotenoids in higher plants,” The FASEB Journal, vol. 10, no. 4, pp. 403–412, 1996. View at Publisher · View at Google Scholar
  3. N. Nisar, L. Li, S. Lu, N. C. Khin, and B. J. Pogson, “Carotenoid metabolism in plants,” Molecular Plant, vol. 8, no. 1, pp. 68–82, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Britton, “Structure and properties of carotenoids in relation to function,” The FASEB Journal, vol. 9, no. 15, pp. 1551–1558, 1995. View at Publisher · View at Google Scholar
  5. J. Widomska, M. Zareba, and W. K. Subczynski, “Can xanthophyll-membrane interactions explain their selective presence in the retina and brain?” Foods, vol. 5, no. 4, p. 7, 2016. View at Publisher · View at Google Scholar
  6. J. Guest and R. Grant, “Carotenoids and neurobiological health,” The Benefits of Natural Products for Neurodegenerative Diseases, vol. 12, pp. 199–228, 2016. View at Publisher · View at Google Scholar
  7. F. Khachik, G. R. Beecher, M. B. Goli, and W. R. Lusby, “Separation, identification, and quantification of carotenoids in fruits, vegetables and human plasma by high performance liquid chromatography,” Pure and Applied Chemistry, vol. 63, no. 1, pp. 71–80, 1991. View at Publisher · View at Google Scholar · View at Scopus
  8. H. E. Khoo, K. N. Prasad, K. W. Kong, Y. Jiang, and A. Ismail, “Carotenoids and their isomers: color pigments in fruits and vegetables,” Molecules, vol. 16, no. 2, pp. 1710–1738, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Khachik, G. R. Beecher, and N. F. Whittaker, “Separation, identification, and quantification of the major carotenoid and chlorophyll constituents in extracts of several green vegetables by liquid chromatography,” Journal of Agricultural and Food Chemistry, vol. 34, no. 4, pp. 603–616, 1986. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Li and H. Yuan, “Chromoplast biogenesis and carotenoid accumulation,” Archives of Biochemistry and Biophysics, vol. 539, no. 2, pp. 102–109, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. O. Sommerburg, J. E. E. Keunen, A. C. Bird, and F. J. G. M. van Kuijk, “Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes,” British Journal of Ophthalmology, vol. 82, no. 8, pp. 907–910, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Schweiggert and R. Carle, “Carotenoid deposition in plant and animal foods and its impact on bioavailability,” Critical Reviews in Food Science and Nutrition, vol. 57, no. 9, pp. 1807–1830, 2017. View at Publisher · View at Google Scholar · View at Scopus
  13. P. J. M. Hulshof, T. van Roekel-Jansen, P. van de Bovenkamp, and C. E. West, “Variation in retinol and carotenoid content of milk and milk products in the Netherlands,” Journal of Food Composition and Analysis, vol. 19, no. 1, pp. 67–75, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Bjerkeng, “Carotenoids in aquaculture: fish and crustaceans,” Carotenoids, vol. 4, pp. 237–254, 2008. View at Publisher · View at Google Scholar
  15. B. S. Dissing, M. E. Nielsen, B. K. Ersbøll, and S. Frosch, “Multispectral imaging for determination of astaxanthin concentration in salmonids,” PLoS One, vol. 6, no. 5, article e19032, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Yan, Y. Chuda, M. Suzuki, and T. Nagata, “Fucoxanthin as the major antioxidant in Hijikia fusiformis, a common edible seaweed,” Bioscience, Biotechnology, and Biochemistry, vol. 63, no. 3, pp. 605–607, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Kanda, Y. Kamo, S. Machmudah, and M. Goto, “Extraction of fucoxanthin from raw macroalgae excluding drying and cell wall disruption by liquefied dimethyl ether,” Marine Drugs, vol. 12, no. 5, pp. 2383–2396, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Craft, T. Haitema, K. Garnett, K. Fitch, and C. Dorey, “Carotenoid, tocopherol, and retinol concentrations in elderly human brain,” The Journal of Nutrition, Health & Aging, vol. 8, no. 3, pp. 156–162, 2004. View at Google Scholar
  19. L. Kaplan, J. Lau, and E. Stein, “Carotenoid composition, concentrations, and relationships in various human organs,” Clinical Physiology and Biochemistry, vol. 8, no. 1, pp. 1–10, 1990. View at Google Scholar
  20. D. W. Nierenberg and S. L. Nann, “A method for determining concentrations of retinol, tocopherol, and five carotenoids in human plasma and tissue samples,” The American Journal of Clinical Nutrition, vol. 56, no. 2, pp. 417–426, 1992. View at Publisher · View at Google Scholar
  21. K. J. Yeum, S. L. Booth, J. A. Sadowski et al., “Human plasma carotenoid response to the ingestion of controlled diets high in fruits and vegetables,” The American Journal of Clinical Nutrition, vol. 64, no. 4, pp. 594–602, 1996. View at Publisher · View at Google Scholar
  22. J. M. Seddon, U. A. Ajani, R. D. Sperduto et al., “Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration,” JAMA, vol. 272, no. 18, pp. 1413–1420, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. R. G. Ziegler, “A review of epidemiologic evidence that carotenoids reduce the risk of cancer,” The Journal of Nutrition, vol. 119, no. 1, pp. 116–122, 1989. View at Publisher · View at Google Scholar
  24. E. Giovannucci, A. Ascherio, E. B. Rimm, M. J. Stampfer, G. A. Colditz, and W. C. Willett, “Intake of carotenoids and retino in relation to risk of prostate cancer,” Journal of the National Cancer Institute, vol. 87, no. 23, pp. 1767–1776, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Voutilainen, T. Nurmi, J. Mursu, and T. H. Rissanen, “Carotenoids and cardiovascular health,” The American Journal of Clinical Nutrition, vol. 83, no. 6, pp. 1265–1271, 2006. View at Publisher · View at Google Scholar
  26. D. Augustynska, M. Jemioła-Rzemińska, K. Burda, and K. Strzałka, “Influence of polar and nonpolar carotenoids on structural and adhesive properties of model membranes,” Chemico-Biological Interactions, vol. 239, pp. 19–25, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Grudzinski, L. Nierzwicki, R. Welc et al., “Localization and orientation of xanthophylls in a lipid bilayer,” Scientific Reports, vol. 7, no. 1, p. 9619, 2017. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Fiedor and K. Burda, “Potential role of carotenoids as antioxidants in human health and disease,” Nutrients, vol. 6, no. 2, pp. 466–488, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Edge, D. McGarvey, and T. Truscott, “The carotenoids as anti-oxidants—a review,” Journal of Photochemistry and Photobiology B: Biology, vol. 41, no. 3, pp. 189–200, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. G. W. Burton and K. Ingold, “Beta-carotene: an unusual type of lipid antioxidant,” Science, vol. 224, no. 4649, pp. 569–573, 1984. View at Publisher · View at Google Scholar
  31. N. J. Miller, J. Sampson, L. P. Candeias, P. M. Bramley, and C. A. Rice-Evans, “Antioxidant activities of carotenes and xanthophylls,” FEBS Letters, vol. 384, no. 3, pp. 240–242, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. G. M. Lowe, L. A. Booth, A. J. Young, and R. F. Bilton, “Lycopene and β-carotene protect against oxidative damage in HT29 cells at low concentrations but rapidly lose this capacity at higher doses,” Free Radical Research, vol. 30, no. 2, pp. 141–151, 1999. View at Publisher · View at Google Scholar
  33. Y. M. Naguib, “Antioxidant activities of astaxanthin and related carotenoids,” Journal of Agricultural and Food Chemistry, vol. 48, no. 4, pp. 1150–1154, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Ochiai, S. Ohno, S. Soeda, H. Tanaka, Y. Shoyama, and H. Shimeno, “Crocin prevents the death of rat pheochromyctoma (PC-12) cells by its antioxidant effects stronger than those of α-tocopherol,” Neuroscience Letters, vol. 362, no. 1, pp. 61–64, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. X. C. Shen and Z. Y. Qian, “Effects of crocetin on antioxidant enzymatic activities in cardiac hypertrophy induced by norepinephrine in rats,” Die Pharmazie-An International Journal of Pharmaceutical Sciences, vol. 61, no. 4, pp. 348–352, 2006. View at Google Scholar
  36. Y. Lorenzo, A. Azqueta, L. Luna, F. Bonilla, G. Dominguez, and A. R. Collins, “The carotenoid β-cryptoxanthin stimulates the repair of DNA oxidation damage in addition to acting as an antioxidant in human cells,” Carcinogenesis, vol. 30, no. 2, pp. 308–314, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Fiedor, A. Sulikowska, A. Orzechowska, L. Fiedor, and K. Burda, “Antioxidant effects of carotenoids in a model pigment-protein complex,” Acta Biochimica Polonica, vol. 59, no. 1, pp. 61–64, 2012. View at Google Scholar
  38. L. E. Voorrips, R. A. Goldbohm, H. A. Brants et al., “A prospective cohort study on antioxidant and folate intake and male lung cancer risk,” Cancer Epidemiology, Biomarkers & Prevention, vol. 9, no. 4, pp. 357–365, 2000. View at Google Scholar
  39. K. Athreya and M. F. Xavier, “Antioxidants in the treatment of cancer,” Nutrition and Cancer, vol. 69, no. 8, pp. 1099–1104, 2017. View at Publisher · View at Google Scholar · View at Scopus
  40. E. J. Johnson, “Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan,” Nutrition Reviews, vol. 72, no. 9, pp. 605–612, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. Age-Related Eye Disease Study Research Group, “The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS report no. 22,” Archives of Ophthalmology, vol. 125, no. 9, pp. 1225–1232, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. Age-Related Eye Disease Study 2 (AREDS2) Research Group, E. Y. Chew, J. P. San Giovanni et al., “Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4,” JAMA Ophthalmology, vol. 131, no. 7, pp. 843–850, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. The Age-Related Eye Disease Study 2 (AREDS2) Research Group, E. Y. Chew, T. E. Clemons et al., “Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report no. 3,” JAMA Ophthalmology, vol. 132, no. 2, pp. 142–149, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Parmeggiani, M. R. Romano, C. Costagliola et al., “Mechanism of inflammation in age-related macular degeneration,” Mediators of Inflammation, vol. 2012, Article ID 435607, 16 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. M. A. Gammone, G. Riccioni, and N. D’Orazio, “Marine carotenoids against oxidative stress: effects on human health,” Marine Drugs, vol. 13, no. 10, pp. 6226–6246, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Galasso, C. Corinaldesi, and C. Sansone, “Carotenoids from marine organisms: biological functions and industrial applications,” Antioxidants, vol. 6, no. 4, p. 96, 2017. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Masgrau, C. Guaza, R. M. Ransohoff, and E. Galea, “Should we stop saying “glia” and “neuroinflammation”?” Trends in Molecular Medicine, vol. 23, no. 6, pp. 486–500, 2017. View at Publisher · View at Google Scholar · View at Scopus
  48. P. L. McGeer, E. McGeer, and K. Yasojima, “Alzheimer disease and neuroinflammation,” in Advances in Dementia Research, K. Jellinger, R. Schmidt, and M. Windisch, Eds., pp. 53–57, Springer, Vienna, Austria, 2000. View at Publisher · View at Google Scholar
  49. M. Sasaki, Y. Ozawa, T. Kurihara et al., “Neuroprotective effect of an antioxidant, lutein, during retinal inflammation,” Investigative Ophthalmology & Visual Science, vol. 50, no. 3, pp. 1433–1439, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. Q. Bian, S. Gao, J. Zhou et al., “Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells,” Free Radical Biology & Medicine, vol. 53, no. 6, pp. 1298–1307, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Y. Li, F. K. Fung, Z. J. Fu, D. Wong, H. H. L. Chan, and A. C. Y. Lo, “Anti-inflammatory effects of lutein in retinal ischemic/hypoxic injury: in vivo and in vitro studies,” Investigative Ophthalmology & Visual Science, vol. 53, no. 10, pp. 5976–5984, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. L. P. Rubin, G. M. Chan, B. M. Barrett-Reis et al., “Effect of carotenoid supplementation on plasma carotenoids, inflammation and visual development in preterm infants,” Journal of Perinatology, vol. 32, no. 6, pp. 418–424, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. J. E. Kim, R. M. Clark, Y. Park, J. Lee, and M. L. Fernandez, “Lutein decreases oxidative stress and inflammation in liver and eyes of guinea pigs fed a hypercholesterolemic diet,” Nutrition Research and Practice, vol. 6, no. 2, pp. 113–119, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. J. H. Kim, H. J. Na, C. K. Kim et al., “The non-provitamin A carotenoid, lutein, inhibits NF-κB-dependent gene expression through redox-based regulation of the phosphatidylinositol 3-kinase/PTEN/Akt and NF-κB-inducing kinase pathways: role of H2O2 in NF-κB activation,” Free Radical Biology & Medicine, vol. 45, no. 6, pp. 885–896, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. W. Wu, Y. Li, Y. Wu, Y. Zhang, Z. Wang, and X. Liu, “Lutein suppresses inflammatory responses through Nrf2 activation and NF-κB inactivation in lipopolysaccharide-stimulated BV-2 microglia,” Molecular Nutrition & Food Research, vol. 59, no. 9, pp. 1663–1673, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. T. Liu, W. H. Liu, J. S. Zhao, F. Z. Meng, and H. Wang, “Lutein protects against β-amyloid peptide-induced oxidative stress in cerebrovascular endothelial cells through modulation of Nrf-2 and NF-κB,” Cell Biology and Toxicology, vol. 33, no. 1, pp. 57–67, 2017. View at Publisher · View at Google Scholar · View at Scopus
  57. K. N. Nam, Y. M. Park, H. J. Jung et al., “Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells,” European Journal of Pharmacology, vol. 648, no. 1–3, pp. 110–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Franceschelli, M. Pesce, A. Ferrone et al., “Astaxanthin treatment confers protection against oxidative stress in U937 cells stimulated with lipopolysaccharide reducing O2 production,” PLoS One, vol. 9, no. 2, article e88359, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. X. S. Zhang, X. Zhang, Q. Wu et al., “Astaxanthin offers neuroprotection and reduces neuroinflammation in experimental subarachnoid hemorrhage,” Journal of Surgical Research, vol. 192, no. 1, pp. 206–213, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. X. Zhou, F. Zhang, X. Hu et al., “Inhibition of inflammation by astaxanthin alleviates cognition deficits in diabetic mice,” Physiology & Behavior, vol. 151, pp. 412–420, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. P. T. Yeh, H. W. Huang, C. M. Yang, W. S. Yang, and C. H. Yang, “Astaxanthin inhibits expression of retinal oxidative stress and inflammatory mediators in streptozotocin-induced diabetic rats,” PLoS One, vol. 11, no. 1, article e0146438, 2016. View at Publisher · View at Google Scholar · View at Scopus
  62. X. Y. Zhou, F. Zhang, X. T. Hu et al., “Depression can be prevented by astaxanthin through inhibition of hippocampal inflammation in diabetic mice,” Brain Research, vol. 1657, pp. 262–268, 2017. View at Publisher · View at Google Scholar · View at Scopus
  63. D. Zhao, S. H. Kwon, Y. S. Chun, M. Y. Gu, and H. O. Yang, “Anti-neuroinflammatory effects of fucoxanthin via inhibition of Akt/NF-κB and MAPKs/AP-1 pathways and activation of PKA/CREB pathway in lipopolysaccharide-activated BV-2 microglial cells,” Neurochemical Research, vol. 42, no. 2, pp. 667–677, 2017. View at Publisher · View at Google Scholar · View at Scopus
  64. A. K. Sachdeva and K. Chopra, “Lycopene abrogates Aβ (1–42)-mediated neuroinflammatory cascade in an experimental model of Alzheimer’s disease,” The Journal of Nutritional Biochemistry, vol. 26, no. 7, pp. 736–744, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. F. Zhang, Y. Fu, X. Zhou et al., “Depression-like behaviors and heme oxygenase-1 are regulated by lycopene in lipopolysaccharide-induced neuroinflammation,” Journal of Neuroimmunology, vol. 298, pp. 1–8, 2016. View at Publisher · View at Google Scholar · View at Scopus
  66. B. Zhao, B. Ren, R. Guo et al., “Supplementation of lycopene attenuates oxidative stress induced neuroinflammation and cognitive impairment via Nrf2/Nf-κB transcriptional pathway,” Food and Chemical Toxicology, vol. 109, Part 1, pp. 505–516, 2017. View at Publisher · View at Google Scholar · View at Scopus
  67. M. A. Rahman and H. Rhim, “Therapeutic implication of autophagy in neurodegenerative diseases,” BMB Reports, vol. 50, no. 7, pp. 345–354, 2017. View at Publisher · View at Google Scholar · View at Scopus
  68. F. K. Fung, B. Y. Law, and A. C. Lo, “Lutein attenuates both apoptosis and autophagy upon cobalt (II) chloride-induced hypoxia in rat Műller cells,” PLoS One, vol. 11, no. 12, article e0167828, 2016. View at Publisher · View at Google Scholar · View at Scopus
  69. C. J. Chang, J. F. Lin, C. Y. Hsiao et al., “Lutein induces autophagy via beclin-1 upregulation in IEC-6 rat intestinal epithelial cells,” The American Journal of Chinese Medicine, vol. 45, no. 6, pp. 1273–1291, 2017. View at Publisher · View at Google Scholar · View at Scopus
  70. S. J. Sheu, J. L. Chen, Y. S. Bee, Y. A. Chen, S. H. Lin, and C. W. Shu, “Differential autophagic effects of vital dyes in retinal pigment epithelial ARPE-19 and photoreceptor 661W cells,” PLoS One, vol. 12, no. 3, article e0174736, 2017. View at Publisher · View at Google Scholar · View at Scopus
  71. C. Zeng, H. Li, Z. Fan et al., “Crocin-elicited autophagy rescues myocardial ischemia/reperfusion injury via paradoxical mechanisms,” The American Journal of Chinese Medicine, vol. 44, no. 3, pp. 515–530, 2016. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Buyuklu, F. Kandemir, M. Ozkaraca et al., “Beneficial effects of lycopene against contrast medium-induced oxidative stress, inflammation, autophagy, and apoptosis in rat kidney,” Human & Experimental Toxicology, vol. 34, no. 5, pp. 487–496, 2015. View at Publisher · View at Google Scholar · View at Scopus
  73. F. Chen, Z. W. Sun, L. F. Ye, G.-S. Fu, Y. Mou, and S.-J. Hu, “Lycopene protects against apoptosis in hypoxia/reoxygenation-induced H9C2 myocardioblast cells through increased autophagy,” Molecular Medicine Reports, vol. 11, no. 2, pp. 1358–1365, 2015. View at Publisher · View at Google Scholar · View at Scopus
  74. F. Zhang, S. Xing, and Z. Li, “Antagonistic effects of lycopene on cadmium-induced hippocampal dysfunctions in autophagy, calcium homeostatis and redox,” Oncotarget, vol. 8, no. 27, pp. 44720–44731, 2017. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Shen, K. Chen, J. Lu et al., “Protective effect of astaxanthin on liver fibrosis through modulation of TGF-β1 expression and autophagy,” Mediators of Inflammation, vol. 2014, Article ID 954502, 14 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  76. J. Li, F. Wang, Y. Xia et al., “Astaxanthin pretreatment attenuates hepatic ischemia reperfusion-induced apoptosis and autophagy via the ROS/MAPK pathway in mice,” Marine Drugs, vol. 13, no. 6, pp. 3368–3387, 2015. View at Publisher · View at Google Scholar · View at Scopus
  77. L. Zhang, H. Wang, Y. Fan et al., “Fucoxanthin provides neuroprotection in models of traumatic brain injury via the Nrf2-ARE and Nrf2-autophagy pathways,” Scientific Reports, vol. 7, article 46763, 2017. View at Publisher · View at Google Scholar · View at Scopus
  78. K. J. Barnham, C. L. Masters, and A. I. Bush, “Neurodegenerative diseases and oxidative stress,” Nature Reviews Drug Discovery, vol. 3, no. 3, pp. 205–214, 2004. View at Publisher · View at Google Scholar
  79. J. Hardy and D. J. Selkoe, “The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics,” Science, vol. 297, no. 5580, pp. 353–356, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. M. G. Spillantini, M. L. Schmidt, V. M. Y. Lee, J. Q. Trojanowski, R. Jakes, and M. Goedert, “α-Synuclein in Lewy bodies,” Nature, vol. 388, no. 6645, pp. 839-840, 1997. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Neumann, D. M. Sampathu, L. K. Kwong et al., “Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis,” Science, vol. 314, no. 5796, pp. 130–133, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. F. O. Walker, “Huntington’s disease,” The Lancet, vol. 369, no. 9557, pp. 218–228, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. B. Halliwell, “Reactive oxygen species in living systems: source, biochemistry, and role in human disease,” The American Journal of Medicine, vol. 91, no. 3, pp. S14–S22, 1991. View at Publisher · View at Google Scholar · View at Scopus
  84. M. T. Lin and M. F. Beal, “Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases,” Nature, vol. 443, no. 7113, pp. 787–795, 2006. View at Publisher · View at Google Scholar · View at Scopus
  85. B. Uttara, A. V. Singh, P. Zamboni, and R. Mahajan, “Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options,” Current Neuropharmacology, vol. 7, no. 1, pp. 65–74, 2009. View at Publisher · View at Google Scholar · View at Scopus
  86. T. Wyss-Coray and L. Mucke, “Inflammation in neurodegenerative disease—a double-edged sword,” Neuron, vol. 35, no. 3, pp. 419–432, 2002. View at Publisher · View at Google Scholar · View at Scopus
  87. C. K. Glass, K. Saijo, B. Winner, M. C. Marchetto, and F. H. Gage, “Mechanisms underlying inflammation in neurodegeneration,” Cell, vol. 140, no. 6, pp. 918–934, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. T. C. Frank-Cannon, L. T. Alto, F. E. McAlpine, and M. G. Tansey, “Does neuroinflammation fan the flame in neurodegenerative diseases?” Molecular Neurodegeneration, vol. 4, no. 1, p. 47, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. A. Prakash and A. Kumar, “Implicating the role of lycopene in restoration of mitochondrial enzymes and BDNF levels in β-amyloid induced Alzheimer’s disease,” European Journal of Pharmacology, vol. 741, pp. 104–111, 2014. View at Publisher · View at Google Scholar · View at Scopus
  90. S. Katayama, H. Ogawa, and S. Nakamura, “Apricot carotenoids possess potent anti-amyloidogenic activity in vitro,” Journal of Agricultural and Food Chemistry, vol. 59, no. 23, pp. 12691–12696, 2011. View at Publisher · View at Google Scholar · View at Scopus
  91. L. Yu, W. Wang, W. Pang, Z. Xiao, Y. Jiang, and Y. Hong, “Dietary lycopene supplementation improves cognitive performances in tau transgenic mice expressing P301L mutation via inhibiting oxidative stress and tau hyperphosphorylation,” Journal of Alzheimer’s Disease, vol. 57, no. 2, pp. 475–482, 2017. View at Publisher · View at Google Scholar
  92. H. Suganuma, T. Hirano, Y. Arimoto, and T. Inakuma, “Effect of tomato intake on striatal monoamine level in a mouse model of experimental Parkinson’s disease,” Journal of Nutritional Science and Vitaminology, vol. 48, no. 3, pp. 251–254, 2002. View at Publisher · View at Google Scholar · View at Scopus
  93. V. di Matteo, M. Pierucci, G. Di Giovanni et al., “Intake of tomato-enriched diet protects from 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons,” Birth, Life and Death of Dopaminergic Neurons in the Substantia Nigra, vol. 73, pp. 333–341, 2009. View at Publisher · View at Google Scholar
  94. H. Kaur, S. Chauhan, and R. Sandhir, “Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of Parkinson’s disease,” Neurochemical Research, vol. 36, no. 8, pp. 1435–1443, 2011. View at Publisher · View at Google Scholar · View at Scopus
  95. A. Prema, U. Janakiraman, T. Manivasagam, and A. J. Thenmozhi, “Neuroprotective effect of lycopene against MPTP induced experimental Parkinson’s disease in mice,” Neuroscience Letters, vol. 599, pp. 12–19, 2015. View at Publisher · View at Google Scholar · View at Scopus
  96. P. Kumar and A. Kumar, “Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism,” Food and Chemical Toxicology, vol. 47, no. 10, pp. 2522–2530, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. P. Kumar, H. Kalonia, and A. Kumar, “Lycopene modulates nitric oxide pathways against 3-nitropropionic acid-induced neurotoxicity,” Life Sciences, vol. 85, no. 19-20, pp. 711–718, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. R. Sandhir, A. Mehrotra, and S. S. Kamboj, “Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system,” Neurochemistry International, vol. 57, no. 5, pp. 579–587, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. D. Jain and A. Gangshettiwar, “Combination of lycopene, quercetin and poloxamer 188 alleviates anxiety and depression in 3-nitropropionic acid-induced Huntington’s disease in rats,” Journal of Intercultural Ethnopharmacology, vol. 3, no. 4, pp. 186–191, 2014. View at Publisher · View at Google Scholar
  100. M. Qu, L. Li, C. Chen et al., “Protective effects of lycopene against amyloid β-induced neurotoxicity in cultured rat cortical neurons,” Neuroscience Letters, vol. 505, no. 3, pp. 286–290, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. M. Qu, Z. Jiang, Y. Liao, Z. Song, and X. Nan, “Lycopene prevents amyloid (beta)-induced mitochondrial oxidative stress and dysfunctions in cultured rat cortical neurons,” Neurochemical Research, vol. 41, no. 6, pp. 1354–1364, 2016. View at Publisher · View at Google Scholar · View at Scopus
  102. S. Hwang, J. W. Lim, and H. Kim, “Inhibitory effect of lycopene on amyloid-β-induced apoptosis in neuronal cells,” Nutrients, vol. 9, no. 12, p. 883, 2017. View at Publisher · View at Google Scholar · View at Scopus
  103. F. Yi, X. He, and D. Wang, “Lycopene protects against MPP+-induced cytotoxicity by maintaining mitochondrial function in SH-SY5Y cells,” Neurochemical Research, vol. 38, no. 8, pp. 1747–1757, 2013. View at Publisher · View at Google Scholar · View at Scopus
  104. W. Chen, L. Mao, H. Xing et al., “Lycopene attenuates Aβ1–42 secretion and its toxicity in human cell and Caenorhabditis elegans models of Alzheimer disease,” Neuroscience Letters, vol. 608, pp. 28–33, 2015. View at Publisher · View at Google Scholar · View at Scopus
  105. J. Lin, J. Yu, J. Zhao et al., “Fucoxanthin, a marine carotenoid, attenuates β-amyloid oligomer-induced neurotoxicity possibly via regulating the PI3k/Akt and the ERK pathways in SH-SY5Y cells,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 6792543, 10 pages, 2017. View at Publisher · View at Google Scholar · View at Scopus
  106. S. Xiang, F. Liu, J. Lin et al., “Fucoxanthin inhibits β-amyloid assembly and attenuates β-amyloid oligomer-induced cognitive impairments,” Journal of Agricultural and Food Chemistry, vol. 65, no. 20, pp. 4092–4102, 2017. View at Publisher · View at Google Scholar · View at Scopus
  107. C. H. Chang, C. Y. Chen, J. Y. Chiou, R. Y. Peng, and C. H. Peng, “Astaxanthine secured apoptotic death of PC12 cells induced by β-amyloid peptide 25–35: its molecular action targets,” Journal of Medicinal Food, vol. 13, no. 3, pp. 548–556, 2010. View at Publisher · View at Google Scholar · View at Scopus
  108. P. Lobos, B. Bruna, A. Cordova et al., “Astaxanthin protects primary hippocampal neurons against noxious effects of Aβ-oligomers,” Neural Plasticity, vol. 2016, Article ID 3456783, 13 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  109. Y. Ikeda, S. Tsuji, A. Satoh, M. Ishikura, T. Shirasawa, and T. Shimizu, “Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells,” Journal of Neurochemistry, vol. 107, no. 6, pp. 1730–1740, 2008. View at Publisher · View at Google Scholar · View at Scopus
  110. D. H. Lee, C. S. Kim, and Y. J. Lee, “Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro,” Food and Chemical Toxicology, vol. 49, no. 1, pp. 271–280, 2011. View at Publisher · View at Google Scholar · View at Scopus
  111. Q. Ye, B. Huang, X. Zhang, Y. Zhu, and X. Chen, “Astaxanthin protects against MPP+-induced oxidative stress in PC12 cells via the HO-1/NOX2 axis,” BMC Neuroscience, vol. 13, no. 1, p. 156, 2012. View at Publisher · View at Google Scholar · View at Scopus
  112. Q. Ye, X. Zhang, B. Huang, Y. Zhu, and X. Chen, “Astaxanthin suppresses MPP+-induced oxidative damage in PC12 cells through a Sp1/NR1 signaling pathway,” Marine Drugs, vol. 11, no. 12, pp. 1019–1034, 2013. View at Publisher · View at Google Scholar · View at Scopus
  113. R. Isonaka, H. Hiruma, T. Katakura, and T. Kawakami, “Inhibition of superoxide dismutase selectively suppresses growth of rat spinal motor neurons: comparison with phosphorylated neurofilament-containing spinal neurons,” Brain Research, vol. 1425, pp. 13–19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  114. A. Ghahghaei, S. Z. Bathaie, H. Kheirkhah, and E. Bahraminejad, “The protective effect of crocin on the amyloid fibril formation of Aβ42 peptide in vitro,” Cellular & Molecular Biology Letters, vol. 18, no. 3, pp. 328–339, 2013. View at Publisher · View at Google Scholar · View at Scopus
  115. F. Asadi, A. H. Jamshidi, F. Khodagholi et al., “Reversal effects of crocin on amyloid β-induced memory deficit: modification of autophagy or apoptosis markers,” Pharmacology Biochemistry and Behavior, vol. 139, pp. 47–58, 2015. View at Publisher · View at Google Scholar · View at Scopus
  116. G. F. Zhang, Y. Zhang, and G. Zhao, “Crocin protects PC12 cells against MPP+-induced injury through inhibition of mitochondrial dysfunction and ER stress,” Neurochemistry International, vol. 89, pp. 101–110, 2015. View at Publisher · View at Google Scholar · View at Scopus
  117. M. Hosseini, Z. Rajaei, H. Alaei, and M. Tajadini, “The effects of crocin on 6-OHDA-induced oxidative/nitrosative damage and motor behaviour in hemiparkinsonian rats,” The Malaysian Journal of Medical Sciences, vol. 23, no. 6, pp. 35–43, 2016. View at Publisher · View at Google Scholar · View at Scopus
  118. Z. Rajaei, M. Hosseini, and H. Alaei, “Effects of crocin on brain oxidative damage and aversive memory in a 6-OHDA model of Parkinson’s disease,” Arquivos de Neuro-Psiquiatria, vol. 74, no. 9, pp. 723–729, 2016. View at Publisher · View at Google Scholar · View at Scopus
  119. S. V. Rao, S. C. Yenisetti, and P. S. Rajini, “Evidence of neuroprotective effects of saffron and crocin in a Drosophila model of parkinsonism,” Neurotoxicology, vol. 52, pp. 230–242, 2016. View at Publisher · View at Google Scholar · View at Scopus
  120. J. H. Ahn, Y. Hu, M. Hernandez, and J. R. Kim, “Crocetin inhibits beta-amyloid fibrillization and stabilizes beta-amyloid oligomers,” Biochemical and Biophysical Research Communications, vol. 414, no. 1, pp. 79–83, 2011. View at Publisher · View at Google Scholar · View at Scopus
  121. Y. Kong, L. P. Kong, T. Luo et al., “The protective effects of crocetin on Aβ1–42-induced toxicity in Ht22 cells,” CNS & Neurological Disorders-Drug Targets, vol. 13, no. 9, pp. 1627–1632, 2014. View at Publisher · View at Google Scholar
  122. R. Tiribuzi, L. Crispoltoni, V. Chiurchiù et al., “trans-Crocetin improves amyloid-β degradation in monocytes from Alzheimer’s disease patients,” Journal of the Neurological Sciences, vol. 372, pp. 408–412, 2017. View at Publisher · View at Google Scholar · View at Scopus
  123. Q. Dai, A. R. Borenstein, Y. Wu, J. C. Jackson, and E. B. Larson, “Fruit and vegetable juices and Alzheimer’s disease: the Kame Project,” The American Journal of Medicine, vol. 119, no. 9, pp. 751–759, 2006. View at Publisher · View at Google Scholar · View at Scopus
  124. F. J. Li, L. Shen, and H. F. Ji, “Dietary intakes of vitamin E, vitamin C, and β-carotene and risk of Alzheimer’s disease: a meta-analysis,” Journal of Alzheimer’s Disease, vol. 31, no. 2, pp. 253–258, 2012. View at Publisher · View at Google Scholar · View at Scopus
  125. E. Kesse-Guyot, V. A. Andreeva, V. Ducros et al., “Carotenoid-rich dietary patterns during midlife and subsequent cognitive function,” British Journal of Nutrition, vol. 111, no. 5, pp. 915–923, 2014. View at Publisher · View at Google Scholar · View at Scopus
  126. N. M. Honarvar, A. Saedisomeolia, M. Abdolahi et al., “Molecular anti-inflammatory mechanisms of retinoids and carotenoids in Alzheimer’s disease: a review of current evidence,” Journal of Molecular Neuroscience, vol. 61, no. 3, pp. 289–304, 2017. View at Publisher · View at Google Scholar · View at Scopus
  127. Z. Zaman, S. Roche, P. Fielden, P. G. Frost, D. C. Niriella, and A. C. D. Cayley, “Plasma concentrations of vitamins A and E and carotenoids in Alzheimer’s disease,” Age and Ageing, vol. 21, no. 2, pp. 91–94, 1992. View at Publisher · View at Google Scholar · View at Scopus
  128. F. J. Jiménez-Jiménez, J. A. Molina, F. Bustos et al., “Serum levels of β-carotene, α-carotene and vitamin A in patients with Alzheimer’s disease,” European Journal of Neurology, vol. 6, no. 4, pp. 495–497, 1999. View at Publisher · View at Google Scholar
  129. W. Wang, L. Shinto, W. E. Connor, and J. F. Quinn, “Nutritional biomarkers in Alzheimer’s disease: the association between carotenoids, n-3 fatty acids, and dementia severity,” Journal of Alzheimer’s Disease, vol. 13, no. 1, pp. 31–38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  130. K. Mullan, M. A. Williams, C. R. Cardwell et al., “Serum concentrations of vitamin E and carotenoids are altered in Alzheimer’s disease: a case-control study,” Alzheimer’s & Dementia: Translational Research & Clinical Interventions, vol. 3, no. 3, pp. 432–439, 2017. View at Publisher · View at Google Scholar · View at Scopus
  131. C. Feart, L. Letenneur, C. Helmer et al., “Plasma carotenoids are inversely associated with dementia risk in an elderly French cohort,” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 71, no. 5, pp. 683–688, 2016. View at Publisher · View at Google Scholar · View at Scopus
  132. J. M. Nolan, E. Loskutova, A. N. Howard et al., “Macular pigment, visual function, and macular disease among subjects with Alzheimer’s disease: an exploratory study,” Journal of Alzheimer’s Disease, vol. 42, no. 4, pp. 1191–1202, 2014. View at Publisher · View at Google Scholar · View at Scopus
  133. J. Y. Min and K. B. Min, “Serum lycopene, lutein and zeaxanthin, and the risk of Alzheimer’s disease mortality in older adults,” Dementia and Geriatric Cognitive Disorders, vol. 37, no. 3-4, pp. 246–256, 2014. View at Publisher · View at Google Scholar · View at Scopus
  134. T. Kiko, K. Nakagawa, A. Satoh et al., “Amyloid β levels in human red blood cells,” PLoS One, vol. 7, no. 11, article e49620, 2012. View at Publisher · View at Google Scholar · View at Scopus
  135. B. F. de Oliveira, C. A. Veloso, J. A. Nogueira-Machado et al., “Ascorbic acid, alpha-tocopherol, and beta-carotene reduce oxidative stress and proinflammatory cytokines in mononuclear cells of Alzheimer’s disease patients,” Nutritional Neuroscience, vol. 15, no. 6, pp. 244–251, 2012. View at Publisher · View at Google Scholar · View at Scopus
  136. Y. Lu, Y. An, J. Guo et al., “Dietary intake of nutrients and lifestyle affect the risk of mild cognitive impairment in the Chinese elderly population: a cross-sectional study,” Frontiers in Behavioral Neuroscience, vol. 10, article 00229, 2016. View at Publisher · View at Google Scholar · View at Scopus
  137. A. Takeda, O. P. Nyssen, A. Syed, E. Jansen, B. Bueno-de-Mesquita, and V. Gallo, “Vitamin A and carotenoids and the risk of Parkinson’s disease: a systematic review and meta-analysis,” Neuroepidemiology, vol. 42, no. 1, pp. 25–38, 2014. View at Publisher · View at Google Scholar · View at Scopus
  138. J. H. Kim, J. Hwang, E. Shim, E. J. Chung, S. H. Jang, and S. B. Koh, “Association of serum carotenoid, retinol, and tocopherol concentrations with the progression of Parkinson’s disease,” Nutrition Research and Practice, vol. 11, no. 2, pp. 114–120, 2017. View at Publisher · View at Google Scholar · View at Scopus
  139. K. C. Hughes, X. Gao, I. Y. Kim et al., “Intake of antioxidant vitamins and risk of Parkinson’s disease,” Movement Disorders, vol. 31, no. 12, pp. 1909–1914, 2016. View at Publisher · View at Google Scholar · View at Scopus
  140. K. C. Fitzgerald, É. J. O’Reilly, E. Fondell et al., “Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: pooled results from 5 cohort studies,” Annals of Neurology, vol. 73, no. 2, pp. 236–245, 2013. View at Publisher · View at Google Scholar · View at Scopus
  141. J. W. Nieves, C. Gennings, P. Factor-Litvak et al., “Association between dietary intake and function in amyotrophic lateral sclerosis,” JAMA Neurology, vol. 73, no. 12, pp. 1425–1432, 2016. View at Publisher · View at Google Scholar · View at Scopus
  142. S. A. Paiva and R. M. Russell, “β-Carotene and other carotenoids as antioxidants,” Journal of the American College of Nutrition, vol. 18, no. 5, pp. 426–433, 1999. View at Publisher · View at Google Scholar · View at Scopus
  143. W. Stahl and H. Sies, “Antioxidant activity of carotenoids,” Molecular Aspects of Medicine, vol. 24, no. 6, pp. 345–351, 2003. View at Publisher · View at Google Scholar · View at Scopus
  144. J. Lakey-Beitia, D. Doens, D. J. Kumar et al., “Anti-amyloid aggregation activity of novel carotenoids: implications for Alzheimer’s drug discovery,” Clinical Interventions in Aging, vol. Volume 12, pp. 815–822, 2017. View at Publisher · View at Google Scholar · View at Scopus
  145. T. Finkel and N. J. Holbrook, “Oxidants, oxidative stress and the biology of ageing,” Nature, vol. 408, no. 6809, pp. 239–247, 2000. View at Publisher · View at Google Scholar · View at Scopus
  146. E. M. Conner and M. B. Grisham, “Inflammation, free radicals, and antioxidants,” Nutrition, vol. 12, no. 4, pp. 274–277, 1996. View at Publisher · View at Google Scholar · View at Scopus
  147. S. Li, X. Liu, J. Lei, J. Yang, P. Tian, and Y. Gao, “Crocin protects podocytes against oxidative stress and inflammation induced by high glucose through inhibition of NF-κB,” Cellular Physiology and Biochemistry, vol. 42, no. 4, pp. 1481–1492, 2017. View at Publisher · View at Google Scholar · View at Scopus
  148. A. G. Mazumder, P. Sharma, V. Patial, and D. Singh, “Crocin attenuates kindling development and associated cognitive impairments in mice via inhibiting reactive oxygen species-mediated NF-κB activation,” Basic and Clinical Pharmacology and Toxicology, vol. 120, no. 5, pp. 426–433, 2017. View at Publisher · View at Google Scholar · View at Scopus
  149. K. Sahin, C. Orhan, F. Akdemir et al., “β-Cryptoxanthin ameliorates metabolic risk factors by regulating NF-κB and Nrf2 pathways in insulin resistance induced by high-fat diet in rodents,” Food and Chemical Toxicology, vol. 107, Part A, pp. 270–279, 2017. View at Publisher · View at Google Scholar · View at Scopus
  150. F. Wang, N. Wang, Y. Gao et al., “β-Carotene suppresses osteoclastogenesis and bone resorption by suppressing NF-κB signaling pathway,” Life Sciences, vol. 174, pp. 15–20, 2017. View at Publisher · View at Google Scholar · View at Scopus
  151. M. Zhang, Z. Cui, H. Cui, Y. Wang, and C. Zhong, “Astaxanthin protects astrocytes against trauma-induced apoptosis through inhibition of NKCC1 expression via the NF-κB signaling pathway,” BMC Neuroscience, vol. 18, no. 1, p. 42, 2017. View at Publisher · View at Google Scholar · View at Scopus
  152. X. Zhou, S. Wang, X. Ding et al., “Zeaxanthin improves diabetes-induced cognitive deficit in rats through activating PI3K/AKT signaling pathway,” Brain Research Bulletin, vol. 132, pp. 190–198, 2017. View at Publisher · View at Google Scholar · View at Scopus
  153. A. R. Mangels, J. M. Holden, G. R. Beecher, M. R. Forman, and E. Lanza, “Carotenoid content of fruits and vegetables: an evaluation of analytic data,” Journal of the American Dietetic Association, vol. 93, no. 3, pp. 284–296, 1993. View at Publisher · View at Google Scholar · View at Scopus
  154. L. Englberger, I. Darnton-Hill, T. Coyne, M. H. Fitzgerald, and G. C. Marks, “Carotenoid-rich bananas: a potential food source for alleviating vitamin A deficiency,” Food and Nutrition Bulletin, vol. 24, no. 4, pp. 303–318, 2003. View at Publisher · View at Google Scholar · View at Scopus
  155. L. M. J. de Carvalho, L. de Azevedo Sarmet Moreira Smiderle, J. L. V. de Carvalho, F. de Souza Neves Cardoso, and M. G. B. Koblitz, “Assessment of carotenoids in pumpkins after different home cooking conditions,” Food Science and Technology, vol. 34, no. 2, pp. 365–370, 2014. View at Publisher · View at Google Scholar · View at Scopus
  156. F. Zaccari and G. Galietta, “α-Carotene and β-carotene content in raw and cooked pulp of three mature stage winter squash “type butternut”,” Food, vol. 4, no. 4, pp. 477–486, 2015. View at Publisher · View at Google Scholar
  157. I. A. Lee, J. H. Lee, N. I. Baek, and D. H. Kim, “Antihyperlipidemic effect of crocin isolated from the fructus of Gardenia jasminoides and its metabolite crocetin,” Biological and Pharmaceutical Bulletin, vol. 28, no. 11, pp. 2106–2110, 2005. View at Publisher · View at Google Scholar · View at Scopus
  158. M. Giaccio, “Crocetin from saffron: an active component of an ancient spice,” Critical Reviews in Food Science and Nutrition, vol. 44, no. 3, pp. 155–172, 2004. View at Publisher · View at Google Scholar · View at Scopus
  159. T. Q. Pham, F. Cormier, E. Farnworth, V. H. Tong, and M. R. Van Calsteren, “Antioxidant properties of crocin from Gardenia jasminoides Ellis and study of the reactions of crocin with linoleic acid and crocin with oxygen,” Journal of Agricultural and Food Chemistry, vol. 48, no. 5, pp. 1455–1461, 2000. View at Publisher · View at Google Scholar · View at Scopus
  160. H. Hosseinzadeh, H. R. Sadeghnia, T. Ziaee, and A. Danaee, “Protective effect of aqueous saffron extract (Crocus sativus L.) and crocin, its active constituent, on renal ischemia-reperfusion-induced oxidative damage in rats,” Journal of Pharmacy & Pharmaceutical Sciences, vol. 8, no. 3, pp. 387–393, 2005. View at Google Scholar
  161. D. E. Breithaupt and A. Bamedi, “Carotenoid esters in vegetables and fruits: a screening with emphasis on β-cryptoxanthin esters,” Journal of Agricultural and Food Chemistry, vol. 49, no. 4, pp. 2064–2070, 2001. View at Publisher · View at Google Scholar · View at Scopus
  162. E. S. M. Abdel-Aal, H. Akhtar, K. Zaheer, and R. Ali, “Dietary sources of lutein and zeaxanthin carotenoids and their role in eye health,” Nutrients, vol. 5, no. 4, pp. 1169–1185, 2013. View at Publisher · View at Google Scholar · View at Scopus
  163. I. Jaswir, N. Shahidan, R. Othman, Y. Z. Has-Yun Hashim, F. Octavianti, and M. N. . Salleh, “Effects of season and storage period on accumulation of individual carotenoids in pumpkin flesh (Cucurbita moschata),” Journal of Oleo Science, vol. 63, no. 8, pp. 761–767, 2014. View at Publisher · View at Google Scholar · View at Scopus
  164. U. Chandrika, K. Fernando, and K. Ranaweera, “Carotenoid content and in vitro bioaccessibility of lycopene from guava (Psidium guajava) and watermelon (Citrullus lanatus) by high-performance liquid chromatography diode array detection,” International Journal of Food Sciences and Nutrition, vol. 60, no. 7, pp. 558–566, 2009. View at Publisher · View at Google Scholar · View at Scopus
  165. D. P. S. Oberoi and D. S. Sogi, “Utilization of watermelon pulp for lycopene extraction by response surface methodology,” Food Chemistry, vol. 232, pp. 316–321, 2017. View at Publisher · View at Google Scholar · View at Scopus
  166. K. Miyashita, S. Nishikawa, F. Beppu, T. Tsukui, M. Abe, and M. Hosokawa, “The allenic carotenoid fucoxanthin, a novel marine nutraceutical from brown seaweeds,” Journal of the Science of Food and Agriculture, vol. 91, no. 7, pp. 1166–1174, 2011. View at Publisher · View at Google Scholar · View at Scopus
  167. J. Nataraj, T. Manivasagam, A. J. Thenmozhi, and M. M. Essa, “Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress,” Nutritional Neuroscience, vol. 19, no. 6, pp. 237–246, 2016. View at Publisher · View at Google Scholar · View at Scopus
  168. Y. Binawade and A. Jagtap, “Neuroprotective effect of lutein against 3-nitropropionic acid-induced Huntington’s disease-like symptoms: possible behavioral, biochemical, and cellular alterations,” Journal of Medicinal Food, vol. 16, no. 10, pp. 934–943, 2013. View at Publisher · View at Google Scholar · View at Scopus